Tim Xu

Director/Board Member at Optikira LLC

Health Technology

Profile

Tim Xu is currently a Member of the Board of Directors at Optikira LLC.
Previously, he served as a Board Observer of the Board of Directors at Amplyx Pharmaceuticals, Inc.

Tim Xu active positions

Companies	Position	Start
Optikira LLC Optikira LLC BiotechnologyHealth Technology Optikira LLC engages in the development of novel therapeutics to prevent cell death diseases such as retinitis pigmentosa, diabetes, and amyotrophic lateral sclerosis. The company was founded by Bradley Backes, Dustin Maly, Scott Oakes, and Feroz Papa in 2015 and is headquartered in Cleveland, OH.	Director/Board Member	-

All active positions of Tim Xu

Former positions of Tim Xu

Companies	Position	End
Amplyx Pharmaceuticals, Inc. Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA.	Director/Board Member	-

See the detail of Tim Xu's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tim Xu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Optikira LLC Optikira LLC BiotechnologyHealth Technology Optikira LLC engages in the development of novel therapeutics to prevent cell death diseases such as retinitis pigmentosa, diabetes, and amyotrophic lateral sclerosis. The company was founded by Bradley Backes, Dustin Maly, Scott Oakes, and Feroz Papa in 2015 and is headquartered in Cleveland, OH.	Health Technology
Amplyx Pharmaceuticals, Inc. Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA.	Health Technology